Congenital adrenal hyperplasia: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Congenital adrenal hyperplasia}}
{{21-hydroxylase deficiency}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}  
==[[Congenital adrenal hyperplasia overview|Overview]]==
==[[21-hydroxylase deficiency overview|Overview]]==


==[[Congenital adrenal hyperplasia historical perspective|Historical Perspective]]==
==[[21-hydroxylase deficiency historical perspective|Historical Perspective]]==


==[[Congenital adrenal hyperplasia classification|Classification]]==
==[[21-hydroxylase deficiency classification|Classification]]==


==[[Congenital adrenal hyperplasia pathophysiology|Pathophysiology]]==
==[[21-hydroxylase deficiency pathophysiology|Pathophysiology]]==


==[[Congenital adrenal hyperplasia causes|Causes]]==
==[[21-hydroxylase deficiency causes|Causes]]==


==[[Congenital adrenal hyperplasia differential diagnosis|Differentiating Congenital Adrenal Hyperplasia from other Diseases]]==
==[[21-hydroxylase deficiency differential diagnosis|Differentiating Congenital Adrenal Hyperplasia from other Diseases]]==


==[[Congenital adrenal hyperplasia epidemiology and demographics|Epidemiology and Demographics]]==
==[[21-hydroxylase deficiency epidemiology and demographics|Epidemiology and Demographics]]==


==[[Congenital adrenal hyperplasia risk factors|Risk Factors]]==  
==[[21-hydroxylase deficiency risk factors|Risk Factors]]==  


==[[Congenital adrenal hyperplasia screening|Screening]]==  
==[[21-hydroxylase deficiency screening|Screening]]==  


==[[Congenital adrenal hyperplasia natural history|Natural History, Complications and Prognosis]]==
==[[21-hydroxylase deficiency natural history|Natural History, Complications and Prognosis]]==


==Diagnosis==
==Diagnosis==

Revision as of 13:19, 12 July 2017

Congenital adrenal hyperplasia main page

21-hydroxylase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 21-Hydroxylase Deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Congenital adrenal hyperplasia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Congenital adrenal hyperplasia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congenital adrenal hyperplasia

CDC on Congenital adrenal hyperplasia

Congenital adrenal hyperplasia in the news

Blogs on Congenital adrenal hyperplasia

Directions to Hospitals Treating 21-Hydroxylase Deficiency

Risk calculators and risk factors for Congenital adrenal hyperplasia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Congenital Adrenal Hyperplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:WH Template:WS